Mus musculus Protein: Tnfaip3
Summary
InnateDB Protein IDBP-135794.6
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol Tnfaip3
Protein Name tumor necrosis factor, alpha-induced protein 3
Synonyms A20; Tnfip3;
Species Mus musculus
Ensembl Protein ENSMUSP00000019997
InnateDB Gene IDBG-135792 (Tnfaip3)
Protein Structure
UniProt Annotation
Function Ubiquitin-editing enzyme that contains both ubiquitin ligase and deubiquitinase activities. Involved in immune and inflammatory responses signaled by cytokines, such as TNF-alpha and IL-1 beta, or pathogens via Toll-like receptors (TLRs) through terminating NF-kappa-B activity. Essential component of a ubiquitin-editing protein complex, comprising also RNF11, ITCH and TAX1BP1, that ensures the transient nature of inflammatory signaling pathways. In cooperation with TAX1BP1 promotes disassembly of E2-E3 ubiquitin protein ligase complexes in IL-1R and TNFR-1 pathways; affected are at least E3 ligases TRAF6, TRAF2 and BIRC2, and E2 ubiquitin-conjugating enzymes UBE2N and UBE2D3. In cooperation with TAX1BP1 promotes ubiquitination of UBE2N and proteasomal degradation of UBE2N and UBE2D3. Upon TNF stimulation, deubiquitinates 'Lys-63'-polyubiquitin chains on RIPK1 and catalyzes the formation of 'Lys-48'-polyubiquitin chains. This leads to RIPK1 proteasomal degradation and consequently termination of the TNF- or LPS-mediated activation of NF-kappa-B. Deubiquitinates TRAF6 probably acting on 'Lys-63'-linked polyubiquitin. Upon T-cell receptor (TCR)-mediated T-cell activation, deubiquitinates 'Lys-63'-polyubiquitin chains on MALT1 thereby mediating disassociation of the CBM (CARD11:BCL10:MALT1) and IKK complexes and preventing sustained IKK activation. Deubiquitinates NEMO/IKBKG; the function is facilitated by TNIP1 and leads to inhibition of NF-kappa-B activation. Upon stimulation by bacterial peptidoglycans, probably deubiquitinates RIPK2. Can also inhibit I-kappa-B-kinase (IKK) through a non-catalytic mechanism which involves polyubiquitin; polyubiquitin promotes association with IKBKG and prevents IKK MAP3K7-mediated phosphorylation. Targets TRAF2 for lysosomal degradation. In vitro able to deubiquitinate 'Lys-11'-, 'Lys-48'- and 'Lys-63' polyubiquitin chains. Inhibitor of programmed cell death. Has a role in the function of the lymphoid system. Required for LPS- induced production of proinflammatory cytokines and IFN beta in LPS-tolerized macrophages. {ECO:0000269PubMed:10385526, ECO:0000269PubMed:11389905, ECO:0000269PubMed:15334086, ECO:0000269PubMed:18342009, ECO:0000269PubMed:20185725, ECO:0000269PubMed:23609450}.
Subcellular Localization Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}. Lysosome {ECO:0000250}.
Disease Associations
Tissue Specificity Found in most tissues during development. Strikingly high levels are found in lymphoid organs, including the thymus, spleen, and gut-associated lymphoid tissue. Constitutively expressed in immature and mature thymocyte subpopulations as well as in resting peripheral T-cells; activation of these leads to down-regulation.
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 38 experimentally validated interaction(s) in this database.
They are also associated with 67 interaction(s) predicted by orthology.
Experimentally validated
Total 38 [view]
Protein-Protein 30 [view]
Protein-DNA 8 [view]
Protein-RNA 0
DNA-DNA 0
RNA-RNA 0
DNA-RNA 0
Predicted by orthology
Total 67 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0002020 protease binding
GO:0003677 DNA binding
GO:0004221 ubiquitin thiolesterase activity
GO:0004842 ubiquitin-protein transferase activity
GO:0004843 ubiquitin-specific protease activity
GO:0005515 protein binding
GO:0008270 zinc ion binding
GO:0016874 ligase activity
GO:0019900 kinase binding
GO:0043130 ubiquitin binding
GO:0043621 protein self-association
Biological Process
GO:0001922 B-1 B cell homeostasis
GO:0002237 response to molecule of bacterial origin
GO:0002315 marginal zone B cell differentiation
GO:0002632 negative regulation of granuloma formation
GO:0002634 regulation of germinal center formation
GO:0002637 regulation of immunoglobulin production
GO:0002677 negative regulation of chronic inflammatory response
GO:0006508 proteolysis
GO:0006915 apoptotic process
GO:0006954 inflammatory response
GO:0009611 response to wounding
GO:0010507 negative regulation of autophagy
GO:0016579 protein deubiquitination
GO:0031397 negative regulation of protein ubiquitination
GO:0032088 negative regulation of NF-kappaB transcription factor activity
GO:0032495 response to muramyl dipeptide
GO:0032691 negative regulation of interleukin-1 beta production
GO:0032703 negative regulation of interleukin-2 production
GO:0032715 negative regulation of interleukin-6 production
GO:0032720 negative regulation of tumor necrosis factor production
GO:0034115 negative regulation of heterotypic cell-cell adhesion
GO:0034140 negative regulation of toll-like receptor 3 signaling pathway
GO:0034148 negative regulation of toll-like receptor 5 signaling pathway
GO:0035871 protein K11-linked deubiquitination
GO:0043124 negative regulation of I-kappaB kinase/NF-kappaB signaling
GO:0045087 innate immune response (InnateDB)
GO:0045088 regulation of innate immune response
GO:0045732 positive regulation of protein catabolic process
GO:0045736 negative regulation of cyclin-dependent protein serine/threonine kinase activity
GO:0045824 negative regulation of innate immune response
GO:0048662 negative regulation of smooth muscle cell proliferation
GO:0050728 negative regulation of inflammatory response
GO:0050869 negative regulation of B cell activation
GO:0060548 negative regulation of cell death
GO:0070301 cellular response to hydrogen peroxide
GO:0070429 negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway
GO:0070433 negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway
GO:0070536 protein K63-linked deubiquitination
GO:0070936 protein K48-linked ubiquitination
GO:0071108 protein K48-linked deubiquitination
GO:0071222 cellular response to lipopolysaccharide
GO:0072573 tolerance induction to lipopolysaccharide
GO:1902042 negative regulation of extrinsic apoptotic signaling pathway via death domain receptors
GO:2000347 positive regulation of hepatocyte proliferation
GO:2000349 negative regulation of CD40 signaling pathway
GO:2000352 negative regulation of endothelial cell apoptotic process
Cellular Component
GO:0005634 nucleus
GO:0005737 cytoplasm
GO:0005764 lysosome
GO:0005813 centrosome
GO:0070062 extracellular vesicular exosome
Protein Structure and Domains
PDB ID MGI:1196377
InterPro IPR002653 Zinc finger, A20-type
IPR003323 Ovarian tumour, otubain
PFAM PF01754
PF02338
PRINTS
PIRSF
SMART SM00259
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt Q60769
PhosphoSite PhosphoSite-Q60769
TrEMBL D3Z5R6
UniProt Splice Variant
Entrez Gene 21929
UniGene Mm.472346
RefSeq NP_033423
MGI ID
MGI Symbol Tnfaip3
OMIM
CCDS CCDS23715
HPRD
IMGT
EMBL AC102657 AK151921 U19463
GenPept AAC52153 BAE30799